Table 2.
Multiple regression analysis for PSA, testosterone, prostate volume and PSA density, in relation to DM, studying BMI as a confounding factor
| B | SE | t | p | 95% CI |
|||
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| PSA | DM | 0.743 | 0.155 | 4.795∗ | < 0.001 | 0.439 | 1.048 |
| BMI | −0.166 | 0.016 | 10.359∗ | < 0.001 | −0.197 | −0.134 | |
| F = 87.977*, P < 0.001*, R = 0.511, R2 = 0.261 | |||||||
| Testosterone | DM | 0.400 | 0.165 | 2.420* | 0.016 | 0.075 | 0.724 |
| BMI | −0.210 | 0.017 | 12.305* | < 0.001 | −0.243 | −0.176 | |
| F = 96.237*, P < 0.001*, R = 0.528, R2 = 0.279 | |||||||
| Prostate volume | DM | 4.629 | 1.633 | 2.835* | 0.005 | 1.420 | 7.837 |
| BMI | 3.011 | 0.168 | 17.883* | < 0.001 | 2.680 | 3.341 | |
| F = 136.430*, P < 0.001*, R = 0.629, R2 = 0.396 | |||||||
| PSA density | DM | 0.020 | 0.004 | 4.853* | < 0.001 | 0.012 | 0.028 |
| BMI | −0.006 | 0.000 | 14.784* | < 0.001 | −0.007 | −0.005 | |
| F = 156.697*, P < 0.001*, R = 0.621, R2 = 0.386 | |||||||
BMI, body mass index; CI, confidence interval; PSA, prostate-specific antigen; SE, standard error.